Varmaca SRL
Varmaca reported total assets of €2.03m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jun 2026).
The score of Varmaca shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +148 % Total assets +1764 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Varmaca's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 238,452 € | ||||
| Equity | 244,786 € | ||||
| Cash | 31,366 € | ||||
| EBITDA | 270,500 € | ||||
| Total assets | €2.03m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 28 May 2025
- Year ended 31 Dec 2023filed on 20 Aug 2024
- Year ended 31 Dec 2022filed on 21 Aug 2023
- Year ended 31 Dec 2021filed on 16 Aug 2022
Varmaca's financial analysis
- Solvency12.1%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Varmaca
Varmaca's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0746.919.695
- VAT number
- BE0746919695
- Peppol
- Registered · 0208:0746919695 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 May 2020
- Registered office
- 3990 Peer
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Varmaca (SRL) has been based in Peer since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 238,452 € and equity of 244,786 €; its revenue is not published. Its solvency stands at 12.1%, below the median of its sector (44.0%).
Companies similar to Varmaca
Companies in the same business, of comparable size and area, outside its group.
- ANAP Retail sale of pharmaceutical products Aalst · balance sheet €1.37m
- Apotheek Schellekens - Lauwers Retail sale of pharmaceutical products Schelle · balance sheet €1.84m
- APR.P.D. Retail sale of pharmaceutical products Hasselt · balance sheet €2.05m
- K-Farma Retail sale of pharmaceutical products Zandhoven · balance sheet €1.94m
- Markri-Farma Retail sale of pharmaceutical products Herent · balance sheet €2.60m
- Pharmacie D'Helecine Retail sale of pharmaceutical products Hélécine · balance sheet €1.22m
- Thomas Broos Retail sale of pharmaceutical products Herent · balance sheet €1.19m
- Pharmanaus Retail sale of pharmaceutical products Herve · balance sheet €1.18m
Frequently asked questions about Varmaca
What is the revenue of Varmaca?
Varmaca files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Varmaca?
In Belgium, the VAT number is the company number prefixed with BE: BE0746919695 for Varmaca, if the company is VAT-registered. Its company number (CBE) is 0746.919.695.
Where is the registered office of Varmaca?
According to the CBE register, the registered office of Varmaca is in 3990 Peer.
What is the equity of Varmaca?
At the close of the 2025 financial year, the equity of Varmaca amounts to 244,786 €, a solvency of 12.1% of total assets.
Who manages Varmaca?
The register lists 1 active mandates at Varmaca. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Varmaca
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →